Trademarkia Logo

Canada

C$
Trademark Search in Canada
MYVI

View On IC.GC.CA

MYVI
ADVERTISED

on 26 Mar 2025

Last Applicant/ Owned by

H. Lundbeck A/S

Ottiliavej 9DK-2500 Valby

DK

Serial Number

2221215 filed on 22nd Aug 2022

Correspondent Address

SMART & BIGGAR LP

Scotia Plaza, 40 King Street West40th FloorToronto

ONTARIO

CA

M5H3Y2

MYVI

Trademark usage description

pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases in, generated from or acting on the central nerv Read More

Classification Information

Class [005]
Pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases in, generated from or acting on the central nervous system, namely central nervous system infections, brain diseases, central nervous system movement disorders, spinal cord diseases; pharmaceutical preparations and substances acting on the central nervous system, namely central nervous system infections, brain diseases, central nervous system movement disorders, spinal cord diseases; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases, namely, cerebral palsy, dementia, Alzheimer's disorder and disease, dizziness, seizures, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety, apathy, epilepsy, Lennox-Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disorder and disease, insomnia, Parkinson's disorder and disease, falls, central nervous system movement disorders and diseases, tremor, schizophrenia, bipolar disorder and disease, mania, ADHD, PTSD, agitation, aggression, autism, melancholy, OCD, Tourette's syndrome, progressive supranuclear palsy (PSP), restlessness, akathisia, fatigue, somnolence, nausea, cancer, alcoholism and alcohol dependency, headache, migraine, pain, immune and inflammatory diseases and disorders, namely, autoimmune diseases, immunologic deficiency syndromes, inflammatory bowel diseases, inflammatory connective tissue diseases, inflammatory muscle diseases and disorders, inflammatory pelvic disease; preparations, substances, reagents and agents for diagnostic and medical purposes, namely medical diagnostic reagents.

Classification kind code

11

Class [044]
Medical, clinical and therapeutic services, as well as healthcare and medical services all in the nature of conducting psychiatric and neurological assessments, examinations and treatments; medical, clinical, therapeutic and health information services, namely providing information in the field of the prevention, screening, diagnosis and treatment of psychiatric and neurological disorders and diseases; services in psychiatry, psychology, neurology and disorders and diseases of the central nervous system, namely, providing medical services for the prevention, screening, diagnosis and treatment of neurological disorders and diseases, cerebral palsy, dementia, Alzheimer's disorder and disease, dizziness, seizures, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety, apathy, epilepsy, Lennox-Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disorder and disease, insomnia, Parkinson's disorder and disease, falls, central nervous system movement disorders and diseases, tremor, schizophrenia, bipolar disorder and disease, mania, ADHD, PTSD, agitation, aggression, autism, melancholy, OCD, Tourette's syndrome, progressive supranuclear palsy (PSP), restlessness, akathisia, fatigue, somnolence, nausea, cancer, alcoholism and alcohol dependency, autoimmune diseases, immunologic deficiency syndromes, inflammatory bowel diseases, inflammatory connective tissue diseases, inflammatory muscle diseases and disorders, inflammatory pelvic disease; advice in connection with medical and pharmaceutical preparations and substances, namely, providing advice in the field of medical prescription information, medication guidance, medication use, and medication safety; healthcare and medical services in the field of central nervous system diseases and disorders and neurological diseases and disorders, and medications for the treatment thereof; provision of medical services and medical information in the field of diagnostics, medicine, pharmaceuticals, relating to the treatment and prevention of pain, headaches, migraines, central nervous system diseases and disorders, neurological diseases and disorders, autoimmune diseases, immunologic deficiency syndromes, inflammatory bowel diseases, inflammatory connective tissue diseases, inflammatory muscle diseases and disorders, inflammatory pelvic disease; providing online medical data and analytics designed to provide patients and clients with patient-specific information about medication dosages, diagnoses, therapeutic treatments and administration of medication relating to the treatment and prevention of pain, headaches, migraines, central nervous system diseases and disorders, neurological diseases and disorders, autoimmune diseases, immunologic deficiency syndromes, inflammatory bowel diseases, inflammatory connective tissue diseases, inflammatory muscle diseases and disorders, inflammatory pelvic disease; providing medical information to medical professionals and patients relating to the prevention, management and treatment of headache, migraine, pain, immune and inflammatory disorders, namely, autoimmune diseases, immunologic deficiency syndromes, inflammatory bowel diseases, inflammatory connective tissue diseases, inflammatory muscle diseases and disorders, inflammatory pelvic diseases, and diseases and neurological disorders and diseases via a website.

Classification kind code

11

Class [045]
Providing personal support to patients in the form of patient support services in connection with the treatment of medical conditions.

Classification kind code

11

Mark Details

Serial Number

2221215

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 48
on 16th Aug 2024		Agent Changed
Submitted for opposition 22
on 27th Feb 2024		Search Recorded
Submitted for opposition 20
on 27th Feb 2024		Examiner's First Report
Submitted for opposition 223
on 27th Feb 2024		Total Provisional Refusal
Submitted for opposition 256
on 11th Sept 2023		Notification of Possible Opposition Sent
Submitted for opposition 257
on 10th Nov 2022		Designation Notification - Madrid Protocol
Submitted for opposition 31
on 10th Nov 2022		Formalized
Submitted for opposition 1
on 9th Nov 2022		Created
Submitted for opposition 30
on 22nd Aug 2022		Filed
Submitted for opposition 228
on 22nd Aug 2022		International Registration

This website uses cookies

We use cookies to ensure you get the best experience. Check our Privacy Policy and Terms & Conditions.
Manage cookies

Manage cookies

You can choose to enable or disable some or all of these cookies but disabling some of them may affect your browsing experience.

Advertisement

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously

Analytics

Analytical cookies are used to understand how visitors interact with the website.

Functional

Functional cookies help perform certain functionalities like collecting feedback, and other third-party features.

Performance

Performance cookies are used to understand and analyze the key performance indexes of the website.